Product Description: Brevicompanine B, a diketopiperazine alkaloid, is an antiplasmodial agent. Brevicompanine B is active against the malaria parasite Plasmodium falciparum 3D7 IC50 of 35 mg/mL[1].
Applications: COVID-19-immunoregulation
Formula: C22H29N3O2
References: [1]Sprogøe K, et, al. Janoxepin and brevicompanine B: antiplasmodial metabolites from the fungus Aspergillus janus. Tetrahedron. Volume 61, Issue 36, 5 September 2005, Pages 8718-8721./[2]Du L, et, al. Diketopiperazine alkaloids from a deep ocean sediment derived fungus Penicillium sp. Chem Pharm Bull (Tokyo).
CAS Number: 215121-47-4
Molecular Weight: 367.48
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Parasite